Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-18T01:41:49.279Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression

Published online by Cambridge University Press:  20 May 2015

Jennifer Lynne Phillips ,
Lisa Ann Batten ,
Philippe Tremblay ,
Fahad Aldosary ,
Lisheng Du  and
Pierre Blier
Jennifer Lynne Phillips*
Affiliation:
University of Ottawa Institute of Mental Health Research, Ottawa, Canada Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada
Lisa Ann Batten
Affiliation:
University of Ottawa Institute of Mental Health Research, Ottawa, Canada
Philippe Tremblay
Affiliation:
University of Ottawa Institute of Mental Health Research, Ottawa, Canada
Fahad Aldosary
Affiliation:
University of Ottawa Institute of Mental Health Research, Ottawa, Canada
Lisheng Du
Affiliation:
University of Ottawa Institute of Mental Health Research, Ottawa, Canada
Pierre Blier
Affiliation:
University of Ottawa Institute of Mental Health Research, Ottawa, Canada Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada
*
Jennifer L. Phillips, University of Ottawa Institute of Mental Health Research, Mood Disorders Research Unit, 1145 Carling Avenue, Ottawa, ON K1Z 7K4, Canada. Tel: +1 613 722 6521; Fax: +1 613 761 3610; E-mail: Jennifer.Phillips@theroyal.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

In major depressive disorder (MDD), single nucleotide polymorphisms (SNPs) in monoaminergic genes may impact disease susceptibility, treatment response, and brain volume. The objective of this study was to examine the effect of such polymorphisms on hippocampal volume in patients with treatment-resistant MDD and healthy controls. Candidate gene risk alleles were hypothesised to be associated with reductions in hippocampal volume.

Methods

A total of 26 outpatients with treatment-resistant MDD and 27 matched healthy controls underwent magnetic resonance imaging and genotyping for six SNPs in monoaminergic genes [serotonin transporter (SLC6A4), norepinephrine transporter (SLC6A2), serotonin 1A and 2A receptors (HTR1A and HTR2A), catechol-O-methyltransferase (COMT), and brain-derived neurotrophic factor (BDNF)]. Hippocampal volume was estimated using an automated segmentation algorithm (FreeSurfer).

Results

Hippocampal volume did not differ between patients and controls. Within the entire study sample irrespective of diagnosis, C allele-carriers for both the NET−182 T/C [rs2242446] and 5-HT1A−1019C/G [rs6295] polymorphisms had smaller hippocampal volumes relative to other genotypes. For the 5-HTTLPR (rs25531) polymorphism, there was a significant diagnosis by genotype interaction effect on hippocampal volume. Among patients only, homozygosity for the 5-HTTLPR short (S) allele was associated with smaller hippocampal volume. There was no association between the 5-HT2A, COMT, and BDNF SNPs and hippocampal volume.

Conclusion

The results indicate that the volume of the hippocampus may be influenced by serotonin- and norepinephrine-related gene polymorphisms. The NET and 5-HT1A polymorphisms appear to have similar effects on hippocampal volume in patients and controls while the 5-HTTLPR polymorphism differentially affects hippocampal volume in the presence of depression.

Keywords

hippocampal volumemagnetic resonance imagingmajor depressive disordersingle nucleotide polymorphism
Type
Original Articles
Information
Acta Neuropsychiatrica , Volume 27 , Issue 6 , December 2015 , pp. 353 - 361
Check for updates
Copyright
© Scandinavian College of Neuropsychopharmacology 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kato, M, Serretti, A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 2010;15:473–500.Google Scholar
2. Scharinger, C, Rabl, U, Pezawas, L, Kasper, S. The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. World J Biol Psychiatry 2011;12:474–488.Google Scholar
3. Mcintyre, RS, Filteau, M-J, Martin, L et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord 2014;156:1–7.Google Scholar
4. Brown, ES, Hughes, CW, Mccoll, R, Peschock, R, King, KS, Rush, AJ. Association of depressive symptoms with hippocampal volume in 1936 adults. Neuropsychopharmacology 2014;39:770–779.Google Scholar
5. Arnone, D, Mcintosh, AM, Ebmeier, KP, Munafò, MR, Anderson, IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol 2012;22:1–16.Google Scholar
6. Campbell, S, Marriott, M, Nahmias, C, Macqueen, GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004;161:598–607.Google Scholar
7. Koolschijn, PCMP, Van Haren, NEM, Lensvelt-Mulders, GJLM, Pol, HEH, Kahn, RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009;30:3719–3735.Google Scholar
8. Mckinnon, MC, Yucel, K, Nazarov, A, Macqueen, GM. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009;34:41–54.Google Scholar
9. Videbech, P, Ravnkilde, B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004;161:1957–1966.Google Scholar
10. Maller, JJ, Daskalakis, ZJ, Thomson, RHS, Daigle, M, Barr, MS, Fitzgerald, PB. Hippocampal volumetrics in treatment-resistant depression and schizophrenia: the devil’s in de-tail. Hippocampus 2012;22:9–16.Google Scholar
11. Shah, PJ, Ebmeier, KP, Glabus, MF, Goodwin, GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Br J Psychiatry 1998;172:527–532.Google Scholar
12. Frodl, T, Möller, H-J, Meisenzahl, E. Neuroimaging genetics: new perspectives in research on major depression? Acta Psychiatr Scand 2008;118:363–372.CrossRefGoogle ScholarPubMed
13. Lloyd, AJ, Ferrier, IN, Barber, R, Gholkar, A, Young, AH, O’brien, JT. Hippocampal volume change in depression: late- and early-onset illness compared. Br J Psychiatry 2004;184:488–495.Google Scholar
14. Frodl, T, Meisenzahl, EM, Zetzsche, T et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 2004;65:492–499.Google Scholar
15. Sheline, YI, Disabato, BM, Hranilovich, J et al. Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry 2012;169:1185–1193.Google Scholar
16. Arnone, D, Mckie, S, Elliott, R et al. State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry 2013;18:1265–1272.CrossRefGoogle ScholarPubMed
17. Phillips, JL, Batten, LA, Aldosary, F, Tremblay, P, Blier, P. Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J Clin Psychiatry 2012;73:625–631.Google Scholar
18. Phillips, JL, Batten, LA, Tremblay, P, Aldosary, F, Blier, P. A prospective, longitudinal study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression. Int J Neuropsychopharmacol. 2015 March 30. doi: 10.1093/ijnp/pyv037. [Epub ahead of print].Google Scholar
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-IV-TR), 4th edn. Washington, DC: American Psychiatric Press, 1994.Google Scholar
20. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.CrossRefGoogle ScholarPubMed
21. Montgomery, SA, Åsberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.Google Scholar
22. First, C, Spitzer, R, Gibson, M, Williams, JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP). New York, NY: Biometrics Research, New York State Psychiatric Institute, 2002.Google Scholar
23. Oldfield, RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113.Google Scholar
24. Dale, AM, Fischl, B, Sereno, MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9:179–194.CrossRefGoogle ScholarPubMed
25. Fischl, B, Sereno, MI, Dale, AM. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195–207.Google Scholar
26. Fischl, B, Salat, DH, Busa, E et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–355.Google Scholar
27. Cherbuin, N, Anstey, KJ, Réglade-Meslin, C, Sachdev, PS. In vivo hippocampal measurement and memory: a comparison of manual tracing and automated segmentation in a large community-based sample. PLoS One 2009;4:e5265.Google Scholar
28. Doring, TM, Kubo, TTA, Cruz, LCH Jr. et al. Evaluation of hippocampal volume based on MR imaging in patients with bipolar affective disorder applying manual and automatic segmentation techniques. J Magn Reson Imaging 2011;33:565–572.CrossRefGoogle ScholarPubMed
29. Morey, RA, Petty, CM, Xu, Y et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage 2009;45:855–866.Google Scholar
30. Sánchez-Benavides, G, Gómez-Ansón, B, Sainz, A, Vives, Y, Delfino, M, Peña-Casanova, J. Manual validation of FreeSurfer’s automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer disease subjects. Psychiatry Res 2010;181:219–225.Google Scholar
31. Buckner, RL, Head, D, Parker, J et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004;23:724–738.CrossRefGoogle ScholarPubMed
32. Serretti, A, Kato, M, De Ronchi, D, Kinoshita, T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007;12:247–257.Google Scholar
33. Nakamura, M, Ueno, S, Sano, A, Tanabe, H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000;5:32–38.Google Scholar
34. Hu, XZ, Lipsky, RH, Zhu, G et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. Am J Hum Genet 2006;78:815–826.CrossRefGoogle ScholarPubMed
35. Lesch, KP, Bengel, D, Heils, A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–1531.Google Scholar
36. Karg, K, Burmeister, M, Shedden, K, Sen, S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited. Arch Gen Psychiatry 2011;68:444–454.Google Scholar
37. Cole, J, Weinberger, DR, Mattay, VS et al. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain and Behav 2011;10:756–764.Google Scholar
38. Hickie, IB, Naismith, SL, Ward, PB et al. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord 2007;98:137–142.Google Scholar
39. Taylor, WD, Steffens, DC, Payne, ME et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005;62:537–544.Google Scholar
40. Sapolsky, RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57:925–935.Google Scholar
41. Tata, DA, Anderson, BJ. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: implications for hippocampal volume reductions in depression. Physiol Behav 2010;99:186–193.CrossRefGoogle ScholarPubMed
42. O’hara, R, Schröder, CM, Mahadevan, R et al. Serotonin transporter polymorphism, memory, and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry 2007;12:544–555.CrossRefGoogle ScholarPubMed
43. Everaerd, D, Gerritsen, L, Rijpkema, M et al. Sex modulates the interactive effect of the serotonin transporter gene polymorphism and childhood adversity on hippocampal volume. Neuropsychopharmacology 2012;37:1848–1855.Google Scholar
44. Frodl, T, Reinhold, E, Koutsouleris, N et al. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 2010;35:1383–1390.CrossRefGoogle ScholarPubMed
45. Eker, MC, Kitis, O, Okur, H et al. Smaller hippocampus volume is associated with short variant of 5-HTTLPR polymorphism in medication-free major depressive disorder patients. Neuropsychobiology 2011;63:22–28.Google Scholar
46. Zill, P, Engel, R, Baghai, TC et al. Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 2002;26:489–493.Google Scholar
47. Zhou, Y, Su, H, Song, J, Guo, L, Sun, Y. Association between norepinephrine transporter T-182C polymorphism and major depressive disorder: a meta-analysis. Neurosci Lett 2014;561:64–68.Google Scholar
48. Yoshida, K, Takahashi, H, Higuchi, H et al. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 2004;161:1575–1580.Google Scholar
49. Albert, PR, Lemonde, S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 2004;10:575–593.Google Scholar
50. Lemonde, S, Tureki, G, Bakish, D et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23:8788–8799.CrossRefGoogle Scholar
51. Le François, B, Czesak, M, Steubl, D, Albert, PR. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008;55:977–985.Google Scholar
52. Dannlowski, U, Ohrmann, P, Bauer, J et al. Serotonergic genes modulate amygdala activity in major depression. Genes Brain and Behav 2007;6:672–676.Google Scholar
53. Zetzsche, T, Preuss, UW, Bondy, B et al. 5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorder. Genes Brain and Behav 2008;7:306–313.Google Scholar
54. Radley, JJ, Jacobs, BL. 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res 2002;955:264–267.Google Scholar
55. Czesak, M, Lemonde, S, Peterson, EA, Rogaeva, A, Albert, PR. Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 2006;26:1864–1871.Google Scholar
56. Czéh, B, Lucassen, PJ. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 2007;257:250–260.Google Scholar
57. Spalding, KL, Bergmann, O, Alkass, K et al. Dynamics of hippocampal neurogenesis in adult humans. Cell 2013;153:1219–1227.CrossRefGoogle ScholarPubMed
58. Gaspar, P, Cases, O, Maroteaux, L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003;4:1002–1012.Google Scholar
59. Gross, C, Zhuang, X, Stark, K et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002;416:396–400.Google Scholar
60. Yan, W, Wilson, CC, Haring, JH. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res Dev Brain Res 1997;98:185–190.Google Scholar